DEBRA KAPLAN: Open Payments
NPI 1790905511 · BERKLEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $210 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: TREMFYA, COSENTYX, DUPIXENT, CIBINQO, RINVOQ, Rhapsido, AKLIEF.
Industry payments across MI — which companies pay providers there.
